20 July 1987
18 March 1987
INTERIM COMMERCIAL ITEM DESCRIPTION
IMIPENEM AND CILASTATIN SODIUM FOR INJECTION
The General Services Administration has authorized the use of this Interim Commercial Item Description which was developed by the Defense Personnel Support Center, Directorate of Medical Material, DPSC-RST, 2800 South 20th Street, Philadelphia, PA 19101, based upon currently available technical information.
Shall be sterile Imipenem and Cilastatin Sodium for Injection.
For Strength 1, shall contain a quantity of Imipenem and Cilastatin Sodium equivalent to 500 mg Imipnem and 500 mg Cilastatin, within the applicable assay limits.
For Strength 2, shall contain a quantity of Imipenem and Cilastatin Sodium equivalent to 250 mg Imipenem and 250 mg Cilastatin, within the applicable assay limits.
All ingredients shall be of pharmaceutical grade.
Workmanship. The injection shall be free from defects which detract from its appearance or impair its serviceability.
Unit. Package (PG).
For Size 1, shall be supplied as a powder in a commercially available bottle with a capacity of 13 ml and adequate room for mixing. One package containing 10 bottles, as specified constitutes one unit.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business